Guangzhou Targene Biotech Co.

BiotechnologySeries AGuangzhou, Chinagztargene.com

Latest round

Series A

Last raised

Mar 2020

Total raised

$14M

Investors

2

About Guangzhou Targene Biotech Co.

, Ltd. is a biotechnology company that focuses on manufacturing, sales, and clinical application of in-vitro diagnostic reagents., Wuhu Dajian Medical Testing Laboratory, and Guangzhou United Easy Inspection Medical Laboratory Co. Ltd. The Wuhu Dajian Medical Testing Laboratory provides molecular testing services, including pathogen nucleic acid testing and early tumor testing. The Guangzhou United Easy Inspection Medical Laboratory Co. Ltd. has a pathology laboratory, gene sequencing lab, and PCR lab, and is equipped with molecular diagnostics platforms. The company provides molecular testing services, including early tumor diagnoses based on methylation testing technology. The in-vitro diagnostic reagents can be used for diagnostic colorectal cancer, bladder cancer, liver cancer, cervical carcinoma, and thyroid cancer. The company will apply for product registration certifications, to expand its market shares, to promote the process of products under development, and to introduce talents.

Who invested in Guangzhou Targene Biotech Co.

2 investors across 1 round

See all investors in Guangzhou Targene Biotech Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 27, 2020

    Amount

    $14M

    Investors

    Locked

Questions about Guangzhou Targene Biotech Co.

Who invested in Guangzhou Targene Biotech Co.?

Guangzhou Targene Biotech Co. has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Guangzhou Targene Biotech Co. raised?

Guangzhou Targene Biotech Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Guangzhou Targene Biotech Co. last raise money?

Guangzhou Targene Biotech Co.'s most recent round on record is a Series A, in Mar 2020.

What does Guangzhou Targene Biotech Co. do?

Guangzhou Targene Biotech Co. is a biotechnology company.

Where is Guangzhou Targene Biotech Co. headquartered?

Guangzhou Targene Biotech Co. is headquartered in Guangzhou, China.

Which VCs invest in companies like Guangzhou Targene Biotech Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Guangzhou Targene Biotech Co.'s stage. Their profiles are linked below.

Raising like Guangzhou Targene Biotech Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.